Market Overview:
The global tumor ablation market reached a value of US$ 634.2 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Tumor ablation refers to a minimally invasive (MI) technique that is conducted to treat tumors of the kidney, liver, bones and lungs. The ablation system consists of a generator and a needlelike device that delivers the heat directly to the target cells to cause acute cellular necrosis. The procedure destroys benign tumors by inserting a probe and heating it to 100-degree Celsius under Precise Computer Tomography, without extracting them from the body. It can be conducted through Microwave Ablation, Radiofrequency Ablation, Cryoablation, etc. It provides increased accuracy and covers a larger treatment area, along with minimal pain and risk to the patient upon repeated administrations.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The increasing prevalence of cancer is one of the key factors driving the growth of the market. Furthermore, owing to benefits such as the lesser amount of trauma, speedy recovery, reduced complications and shorter hospital stay, MI procedures are gaining widespread preference, which, in turn, is driving the market growth. Also, various technological advancements such as the introduction of thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU) have enhanced the acceptance of tumor ablation procedures. Moreover, the implementation of favorable government policies for cancer awareness and treatment methods is also creating a positive outlook for the market. Other factors driving the market include growing healthcare expenditures and rising geriatric population, along with the increasing number of ablation and surgical centers and awareness for ablation procedures that can be conducted over small tumors.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tumor ablation market, along with forecasts at the global and regional level from 2021-2026. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.
Breakup by Technology:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Others
Breakup by Mode of Treatment:
- Percutaneous Ablation
- Laparoscopic Ablation
- Surgical Ablation
Breakup by Mode of Application:
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Others
Breakup by End-User:
- Hospitals
- Cancer Specialty Clinics
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic, AngioDynamics Inc., HealthTronics Inc., NeuWave Medical, INTIO Inc., Galil Medical Ltd., Boston Scientific, Sonacare Medical, EDAP TMS S.A., ERBE Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc., B V M Meditech Pvt., etc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Million |
| Segment Coverage |
Technology, Mode of Treatment, Mode of Application, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered |
Medtronic, AngioDynamics Inc., HealthTronics Inc., NeuWave Medical, INTIO Inc., Galil Medical Ltd., Boston Scientific, Sonacare Medical, EDAP TMS S.A., ERBE Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc. and B V M Meditech Pvt. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global tumor ablation market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global tumor ablation industry?
- What has been the impact of COVID-19 on the global tumor ablation market ?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the mode of treatment?
- What is the breakup of the market based on the mode of application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global tumor ablation industry?
- What are the key driving factors and challenges in the global tumor ablation industry?
- What is the structure of the global tumor ablation industry and who are the key players?
- What is the degree of competition in the global tumor ablation industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Tumor Ablation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Technology
5.5 Market Breakup by Mode of Treatment
5.6 Market Breakup by Mode of Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast
6 SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7 Value Chain Analysis
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Bargaining Power of Buyers
8.3 Bargaining Power of Suppliers
8.4 Degree of Competition
8.5 Threat of New Entrants
8.6 Threat of Substitutes
9 Market Breakup by Technology
9.1 Radiofrequency (RF) Ablation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Microwave Ablation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cryoablation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Mode of Treatment
10.1 Percutaneous Ablation
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Laparoscopic Ablation
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Surgical Ablation
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Mode of Application
11.1 Liver Cancer
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Lung Cancer
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Kidney Cancer
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Bone Metastasis
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 Market Breakup by End-User
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Cancer Specialty Clinics
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Others
12.3.1 Market Trends
12.3.2 Market Forecast
13 Market Breakup by Region
13.1 North America
13.1.1 Market Trends
13.1.2 Market Forecast
13.2 Europe
13.2.1 Market Trends
13.2.2 Market Forecast
13.3 Asia Pacific
13.3.1 Market Trends
13.3.2 Market Forecast
13.4 Middle East and Africa
13.4.1 Market Trends
13.4.2 Market Forecast
13.5 Latin America
13.5.1 Market Trends
13.5.2 Market Forecast
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Medtronic
14.3.2 AngioDynamics Inc
14.3.3 HealthTronics Inc
14.3.4 NeuWave Medical
14.3.5 INTIO Inc
14.3.6 Galil Medical Ltd
14.3.7 Boston Scientific
14.3.8 Sonacare Medical
14.3.9 EDAP TMS S.A.
14.3.10 ERBE Elektromedizin GmbH
14.3.11 IceCure Medical Ltd
14.3.12 MISONIX Inc
14.3.13 Endocare Inc
14.3.14 CooperSurgical Inc
14.3.15 B V M Meditech Pvt
List of Figures
Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
Figure 2: Global: Tumor Ablation Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2020
Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2020
Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2020
Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2020
Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2020
Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
Figure 11: Global: Tumor Ablation Industry: Porter’s Five Forces Analysis
Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: North America: Tumor Ablation Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2021-2026
List of Tables
Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million US$), 2021-2026
Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million US$), 2021-2026
Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Tumor Ablation Market Structure
Table 8: Global: Tumor Ablation Market: Key Players